N/A
N=968
Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk.
Atrial Fibrillation · Stroke
Bottom Line
View on ClinicalTrials.gov: NCT02746107 ↗Enrolled (actual)
968
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcome: Primary: Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Number of Decision Aid Diagrams — 400; 406 participants — p=0.83
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- decision aid (Other)
- Age
- Adult, Older Adult · 24+ yrs
- Sex
- All
- Sponsor
- Cristian Baicus
- Primary completion
- Jun 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Prescribed Oral Anticoagulants (OAC) According to the Number of Decision Aid Diagrams |
400; 406 | 0.83 |
Summary
Randomized study concerning the effect of the number of risk diagrams (with treatment +/- without treatment), the period of stroke risk estimation (one year or five years) and the target of prescription (the patient with atrial fibrillation or the physician himself, imagining she/he has atrial fibrillation) on the intention to prescribe or not oral anticoagulation.
Eligibility Criteria
Inclusion Criteria
- physicians who prescribe anticoagulant treatment for atrial fibrillation (cardiology, internal medicine, family medicine, hematology) or who deal with patients with stroke (neurology, pathology) or bleeding (gastroenterology)
Exclusion Criteria
- physicians who never prescribe anticoagulant treatments, or do not deal with patients with stroke or bleeding because of anticoagulants
Data sourced from ClinicalTrials.gov (NCT02746107). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.